Pfizer Inc. News
Novavax Stock Slides As JPMorgan Slashes Price Target, Lowers Rating
JPMorgan analyst Eric Joseph slashed his price target on Novavax by more than $100, to $27 per share.
Goldman Sachs Lists Most Underweighted Value Stocks
Value stocks will gain whether inflation peaks or the Fed tightens enough to spark a recession, Goldman Sachs said.
Exact Sciences: Don't Deem It Guilty by Association
Genetic-testing stocks, especially those championed by asset manager Cathie Wood, have been pummeled. It's important to differentiate.
Biosimilars Are Saving America $1 Billion Per Month
Competitive drug prices are great for consumers. Turns out, they're good for industry, too.
Moderna Sues Pfizer, BioNtech For Covid Vaccine Patent Infringement
"We believe that Pfizer and BioNTech unlawfully copied Moderna's inventions, and they have continued to use them without permission," Moderna said.
Pfizer Stock Slumps Amid Litigation Concerns Linked to Zantac Heartburn Drug
Zantac, also sold as ranitidine, was pulled from the market in 2020 following a study that suggested it contained a cancer-causing impurity.
Stock Market Today - 8/11: Stocks End Mixed As Cooling Inflation Slows Fed Rate Bets
Stocks finished the day mixed as investors reappraised inflation concerns and the potential impact on interest rates.
Bluebird Bio's 2nd Approval Doesn't Guarantee Survival
Investors hoping for a revival at the struggling biotech might want to temper their expectations.
A’s Likely Headed to Las Vegas Strip After Oakland Drops Ball
A major league sports team is closer than ever to relocating to Las Vegas.